Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. (INTI) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 13 transactions totaling $975, demonstrating a bullish sentiment with $975 in net insider flow. The most recent transaction on Apr 1, 2024 involved a transaction of 50,000 shares valued at $0.
INTI Insider Activity Summary
Who Is Buying INTI Stock?
No significant insider buying has been recorded for INTI in the recent period.
Who Is Selling INTI Stock?
No significant insider selling has been recorded for INTI in the recent period.
Is Inhibitor Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INTI is bullish with an Insider Alignment Score of 100/100 and a net flow of $975. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
INTI Frequently Asked Questions
Understanding INTI Insider Activity
Insider trading at Inhibitor Therapeutics, Inc. (INTI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading INTI stock, having executed 13 transactions in the past 90 days. The most active insider is Garrison J. Hasara (Executive), who has made 1 transactions totaling $945.
Related Tools
Track Inhibitor Therapeutics, Inc. Insider Activity
Get notified when executives and directors at INTI file new Form 4 transactions